• Title/Summary/Keyword: Intravenous Immunoglobulin

Search Result 179, Processing Time 0.033 seconds

Alteration of Biochemical Profiles after High-Dose Intravenous Immunoglobulin Administration in Kawasaki Disease (가와사끼병에서 고용량 정맥용 면역글로불린 투여 후 생화학 지표들의 변화)

  • Lee, Ji-Won;Lee, Kyung-Yil
    • Clinical and Experimental Pediatrics
    • /
    • v.46 no.8
    • /
    • pp.817-820
    • /
    • 2003
  • Purpose : Intravenous immunoglobulin(IVIG) has been used as an immunomodulatory treatment for several immune-mediated diseases. The early effect of high-dose IVIG on biochemical profiles including lipids and proteins was evaluated in patients with Kawasaki disease(KD). Methods : Twelve children with KD(nine boys) were treated with IVIG of 2 g/kg over 12 hours. Serial sera were collected from the patients four times : before IVIG treatment and two hours, 24 hours and seven days after IVIG treatment. The samples were frozen at $-20^{\circ}C$ before biochemical analysis. Results : A significant decrease in albumin concentration was found two hours h and 24 hours after IVIG treatment, but this recovered to the pretreatment level after seven days. Total cholesterol and triglyceride increased slightly after seven day. A significant decrease in HDL-cholesterol and C-reactive protein was seen two hours and 24 hours after IVIG treatment. Conclusion : High-dose IVIG affects immediate changes in protein profiles and HDL-cholesterol in KD. Changes in HDL-cholesterol induced by IVIG may be the result of changes in systemic protein metabolism.

Arthritis in the Subacute Stage of Kawasaki Disease after Responding to Intravenous Immunoglobulin Treatment (가와사끼병에서 정맥용 면역글로불린에 반응 후 아급성기에 발생한 관절염)

  • Lee, Kyung-Yil;Oh, Jin-Hee;Koh, Dea-Kyun
    • Clinical and Experimental Pediatrics
    • /
    • v.46 no.11
    • /
    • pp.1124-1127
    • /
    • 2003
  • We evaluated the clinical and laboratory characteristics of five children with Kawasaki disease who had showed arthritis after responding to intravenous immunoglobulin(IVIG) treatment. Age distribution was between 13 months and six years of age(mean $3.2{\pm}1.6$ years). There were two males and three females. Arthritis occurred when acute symptoms were subsiding, with the average onset on day $5.8{\pm}1.8$ after final IVIG treatment. Arthritis was pauciarticular in three, and polyarticular in two. Regarding laboratory findings, one child was positive in rhematoid factor and changed to negative after two months. Three patients were examined for HLA B27 and all showed negative results. High dose aspirin(two cases), anti-inflammatory drug(ibprofen, three cases), and corticosteroids(methyprednisolon pulse therapy, one case) were used for this type of arthritis. Symptoms and signs of arthritis in all patients were improved by these therapies. There was no relapse or complications within six months. Arthritis after responding to IVIG therapy was rarely observed in children with Kawasaki disease. This type of arthritis responded well to anti-inflammatory drugs including corticosteroids, and showed no relapses.

A 2-month-old boy with hemolytic anemia and reticulocytopenia following intravenous immunoglobulin therapy for Kawasaki disease: a case report and literature review

  • Kim, Na Yeon;Kim, Joon Hwan;Park, Jin Suk;Kim, Soo Hyun;Cho, Yeon Kyung;Cha, Dong Hyun;Kim, Ki Eun;Kang, Myung Suh;Lim, Kyung Ah;Sheen, Youn Ho
    • Clinical and Experimental Pediatrics
    • /
    • v.59 no.sup1
    • /
    • pp.60-63
    • /
    • 2016
  • Herein, we report a rare case of hemolytic anemia with reticulocytopenia following intravenous immunoglobulin therapy in a young infant treated for Kawasaki disease. A 2-month-old boy presented with fever lasting 3 days, conjunctival injection, strawberry tongue, erythematous edema of the hands, and macular rash, symptoms and signs suggestive of incomplete Kawasaki disease. His fever resolved 8 days after treatment with aspirin and high dose infusion of intravenous immunoglobulin. The hemoglobin and hematocrit decreased from 9.7 g/dL and 27.1% to 7.4 g/dL and 21.3%, respectively. The patient had normocytic hypochromic anemia with anisocytosis, poikilocytosis, immature neutrophils, and nucleated red blood cells. The direct antiglobulin test result was positive, and the reticulocyte count was 1.39%. The patient had an uneventful recovery. However, reticulocytopenia persisted 1 month after discharge.

A Clinical Case Study of Patient that Not Improved Thrombocytopenia after Intravenous Immunoglobulin Treatment at Idiopathic Thrombocytopenic Purpura as a Complication of Deep Vein Thrombosis (DVT와 병발한 ITP환자에서 정맥 내 면역글로불린요법 시행 후 호전되지 않는 혈소판감소 환자 치험 1례)

  • Lee, Kyeung A;Jung, Jae Youp;Lee, Eun Sol;Seo, Dong Goon;Sin, So Yeon;Jang, Sun Hui;Yoon, Hyoun Min;Kim, Cheol Hong;Jeong, Jong Hun;Jang, Kyung Jeon
    • Journal of Acupuncture Research
    • /
    • v.30 no.4
    • /
    • pp.203-210
    • /
    • 2013
  • Objectives : The purpose of this study is to report clinical effect of oriental medical for a not improved ITP patient, who developed complication from DVT, after intravenous immunoglobulin treatment. Methods : The patient was treated using Saam acupuncture, herbal medication, moxibustion and physical treatment. And we measured of systemic symptoms and platelet counts. Results : After treatment, systemic symptoms and platelet counts were improved in case. Conclusions : Oriental medical treatment showed significant effect on ITP patient that not improved platelet counts after intravenous immunoglobulin treatment.

Macrophage Activation Syndrome Presented in a Case of Neonatal Lupus

  • Kang, Chang Min;Choi, Jinwha;Lee, JungHwa
    • Neonatal Medicine
    • /
    • v.28 no.3
    • /
    • pp.139-142
    • /
    • 2021
  • Macrophage activation syndrome (MAS) is a potentially life-threatening complication in many autoimmune diseases. Early recognition and intervention are essential for a favorable outcome. Neonatal lupus, an acquired autoimmune disease in neonates caused by the transplacental passage of maternal autoantibodies, is rare and usually self-limited. Herein, we report a case of MAS in a patient with neonatal lupus, which improved with intravenous immunoglobulin.

A Case Report of Integrative Medicine Therapy about Patient Suspected Acute Guillain-Barre Syndrome (급성 Guiilain-Barre Syndrome 추정 환자 동서협진 치험 1례)

  • So, Hyung-Jin;Son, Yoon-Jung;Lee, Beom-Joon;Rho, Byoung-Wan;Lew, Jae-Hwan;Heo, Hong
    • The Journal of Korean Oriental Chronic Disease
    • /
    • v.10 no.1
    • /
    • pp.53-61
    • /
    • 2005
  • Guillain-Barre syndrome (GBS) is a group of autoimmune syndromes consisting of demyelinating and acute axonal degenerating forms of the disease. Typically, Gullain-Barre syndrome can be diagnosed from the patient's symptoms and physical examination such as the rapid onset of weakness, paralysis and loss of reflexes. In most patients, resolution is complete or near complete. Treatment consists of supportive care, ventilatory management (in about one third of patients), and specific therapy with intravenous immunoglobulin or plasmapheresis. This clinical report is about suspected acute severe Guillain-Barre syndrome patient, 61-year-old man had quadriplegia, facial palsy, dysphasia, respiratory failure. After 5 weeks of East-West integrative medicine therapy - Conventional Conservative therapy(plasmaphresis and intravenous immunoglobulin) and Korean traditional medicine(Sasang medicine and acupuncture treatment) - most symptoms improved.

  • PDF